Viral vector-mediated SLC9A6 gene replacement reduces cerebellar motor and molecular abnormalities in the shaker rat model of Christianson syndrome
Gene therapy corrects brain abnormalities in a rare disorder model, suggesting similar approaches could help patients.
This preclinical study demonstrates that AAV-mediated gene replacement corrects cerebellar abnormalities in a Christianson syndrome rat model. Findings support gene replacement as a viable therapeutic strategy for this X-linked rare neurodevelopmental disorder.
What the study was
- Study design
- Preclinical longitudinal gene therapy study
- Population
- Shaker rat model of Christianson syndrome
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Human Molecular Genetics
Why it surfaced
Preclinical gene therapy for ultra-rare Christianson syndrome. Animal model caps score at 5.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.